Alto Capital's Tony Locantro welcomes the news this week from Exopharm Limited (ASX:EX1) of a $12 million capital raise. Placement commitments exceeded the company’s minimum target of $6 million, with strong support from existing and new shareholders including institutional investors. Locantro updates on the performance of some of his gold stocks including Mako Gold Ltd (ASX:MKG) and new investment Golden State Mining Limited (ASX:GSM) as well as why Dogecoin has rocketed more than 8000% so far this year.
Tony Locantro talks Exopharm's $12 million raise, gold and the push to drive Dogecoin
